PV Ennezat, M Berlowitz, EH Sonnenblick, TH … - Current Cardiology Reports, 2000 - Springer Clinical and Laboratory Evidences of Angiotensin-Converting Enzyme Escape in
Chronic Heart Failure Six weeks after enrollment into the Cooperative North
Scandinavian Enalapril Survival Study (CONSENSUS) I trial, patients ... Cited by 19 - Related articles - All 2 versions
DA Sica - J Clin Hypertens, 2003 - interscience.wiley.com Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are
commonly prescribed for the management of hypertension. In addition, each of
these drug classes has been shown to be effective in the treatment of ... Cited by 19 - Related articles - BL Direct - All 2 versions
- ►nih.gov [PDF] JD Bisognano, LD Horwitz - Western Journal of Medicine, 1998 - pubmedcentral.nih.gov THE TREATMENT OF severe essential hypertension can be a difficult clinical
challenge. Despite the wide range of pharmacological options, some patients have
poor blood pressure control even with multidrug therapy. It is well- ... Cited by 12 - Related articles - BL Direct - All 4 versions
S Morimoto, K Maki, Y Aota, T Sakuma, T … - Hypertension Research, 2008 - nature.com The combination of angiotensin I–converting enzyme inhibitors and angiotensin
receptor blockers has been shown to be more effective than the individual drugs
alone in the treatment of chronic kidney disease and chronic heart failure. ... Related articles - All 3 versions
AIIR Blockers - hhsc.state.tx.us Adults Angiotensin II receptor blockers (ARBs) are FDA-approved for use in
hypertension (all available ARBs), diabetic nephropathy (irbesartan, losartan),
heart failure (candesartan, valsartan), and post-myocardial infarction ( ... Related articles - View as HTML - All 2 versions
- ►nbn-resolving.de [PDF] I Voges - deposit.ddb.de Page 1. Aus dem Institut für experimentelle und klinische Pharmakologie und Toxikologie
der Universität zu Lübeck Direktor: Prof. Dr. med. P. Dominiak Studie ... Related articles - All 3 versions
NY SELÇUK - turkhipertansiyon.com ACE inhbitörleri ile tedavide ACE dışı(chymase vb.) yollarla angiotensin II
oluşumu önlenememektedir. ARB'lerle tedavi sırasında angiotensin II
düzeyleri art- maktadır. Angiotensin II düzeylerini maksimum dü- zeyde ... Related articles - View as HTML - All 3 versions
DR Struckman, MP Rivey - The Annals of pharmacotherapy, 2001 - Harvey Whitney Books RESPONSE BACKGROUND Heart failure is increasing in incidence and prevalence,
afflicting 4.8 million persons in the US.1 Despite techno- logical advances in
medicine, the one-year risk of death continues to be 30– 40% in patients ... Cited by 13 - Related articles - BL Direct - All 4 versions
DA Sica, WJ Elliott - J Clin Hypertens, 2001 - interscience.wiley.com Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are
commonly used to treat hypertension and/or a range of progressive end-organ
diseases. The success of each of these drug classes in disease-state ... Cited by 13 - Related articles - BL Direct - All 4 versions
